XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.19.1

Derivative and Other Financial Instruments with Off-Balance Sheet Risks | 9 Months Ended
--- | ---
Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative and Other Financial Instruments with Off-Balance Sheet Risks | Note 7: Derivative and Other Financial Instruments with Off-Balance Sheet Risks The Corporation is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit in the form of originating loans or providing funds under existing lines of credit, loan sale commitments to third parties and option contracts. These instruments involve, to varying degrees, elements of credit and interest-rate risk in excess of the amount recognized in the accompanying Condensed Consolidated Statements of Financial Condition. The Corporation’s exposure to credit loss, in the event of non-performance by the counterparty to these financial instruments, is represented by the contractual amount of these instruments. The Corporation uses the same credit policies in entering into financial instruments with off-balance sheet risk as it does for on-balance sheet instruments. As of March 31, 2019 and June 30, 2018, the Corporation had commitments to extend credit (on loans to be held for investment and loans to be held for sale) of $16.6 million and $66.3 million, respectively. The following table provides information at the dates indicated regarding undisbursed funds on construction loans, undisbursed funds to borrowers on existing lines of credit with the Corporation as well as commitments to originate loans to be held for investment at the dates indicated below.
Commitments |  | March 31, 2019 |  |  | June 30, 2018 |
(In Thousands) |  |  |  |  |  |
Undisbursed loan funds – Construction loans |  | $ | 6,109 |  |  | $ | 4,302 |
Undisbursed lines of credit – Commercial business loans |  |  | 950 |  |  |  | 495 |
Undisbursed lines of credit – Consumer loans |  |  | 481 |  |  |  | 503 |
Commitments to extend credit on loans to be held for investment |  |  | 4,346 |  |  |  | 9,352 |
Total |  | $ | 11,886 |  |  | $ | 14,652 |
The following table provides information regarding the allowance for loan losses for the undisbursed funds and commitments to extend credit on loans to be held for investment for the quarters and nine months ended March 31, 2019 and 2018.
|  | For the Quarters Ended March 31, |  |  | For the Nine Months Ended March 31, |
(In Thousands) |  | 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |
Balance, beginning of the period |  | $ | 150 |  |  | $ | 188 |  |  | $ | 157 |  |  | $ | 277 |
Provision (recovery) |  |  | 1 |  |  |  | (29 | ) |  |  | (6 | ) |  |  | (118 | )
Balance, end of the period |  | $ | 151 |  |  | $ | 159 |  |  | $ | 151 |  |  | $ | 159 |
In accordance with ASC 815, “Derivatives and Hedging,” and interpretations of the Derivatives Implementation Group of the FASB, the fair value of the commitments to extend credit on loans to be held for sale, loan sale commitments, to be announced (“TBA”) MBS trades, put option contracts and call option contracts are recorded at fair value on the Condensed Consolidated Statements of Financial Condition. At March 31, 2019, $240,000 was included in other assets and $224,000 was included in other liabilities; at June 30, 2018, $849,000 was included in other assets and $464,000 was included in other liabilities. The Corporation does not apply hedge accounting to its derivative financial instruments; therefore, all changes in fair value are recorded in earnings. The net impact of derivative financial instruments recorded within the gain on sale of loans contained in the Condensed Consolidated Statements of Operations during the quarters and nine months ended March 31, 2019 and 2018 was as follows:
|  | For the Quarters Ended March 31, |  |  | For the Nine Months Ended March 31, |
Derivative Financial Instruments |  | 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |
(In Thousands) |  |  |  |  |  |  |  |  |  |  |  |
Commitments to extend credit on loans to be held for sale |  | $ | (264 | ) |  | $ | 266 |  |  | $ | (585 | ) |  | $ | 173 |
Mandatory loan sale commitments and TBA MBS trades |  |  | 465 |  |  |  | (281 | ) |  |  | 216 |  |  |  | (1,072 | )
Option contracts, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (37 | )
Total net gain (loss) |  | $ | 201 |  |  | $ | (15 | ) |  | $ | (369 | ) |  | $ | (936 | )
The outstanding derivative financial instruments and other loan sale agreements at the dates indicated were as follows:
|  | March 31, 2019 |  |  | June 30, 2018 |
Derivative Financial Instruments |  | Amount |  |  | Fair Value |  |  | Amount |  |  | Fair Value |
(In Thousands) |  |  |  |  |  |  |  |  |  |  |  |
Commitments to extend credit on loans to be held for sale (1) |  | $ | 12,211 |  |  | $ | 240 |  |  | $ | 56,906 |  |  | $ | 825 |
Best efforts loan sale commitments |  |  | (10,212 | ) |  |  | — |  |  |  | (29,502 | ) |  |  | — |
Mandatory loan sale commitments and TBA MBS trades |  |  | (28,817 | ) |  |  | (224 | ) |  |  | (117,759 | ) |  |  | (440 | )
Total |  | $ | (26,818 | ) |  | $ | 16 |  |  | $ | (90,355 | ) |  | $ | 385 |
| (1) | Net of 18.6% at March 31, 2019 and 24.7% at June 30, 2018 of commitments which management has estimated may not fund.
Occasionally, the Corporation is required to repurchase loans sold to Freddie Mac, Fannie Mae or other institutional investors if it is determined that such loans do not meet the credit requirements of the investor, or if one of the parties involved in the loan misrepresented pertinent facts, committed fraud, or if such loans were 90-days past due within 120 days of the loan funding date. During the third quarter of fiscal 2019, the Corporation repurchased two loans totaling $446,000 pursuant to the recourse/repurchase covenants contained in the loan sale agreements. In comparison, the Corporation repurchased two loans totaling $602,000 from investors during the third quarter of fiscal 2018. During the first nine months of fiscal 2019, the Corporation repurchased five loans totaling $699,000, including two loans that were fully charged off ($25,000). In comparison, the Corporation repurchased two loans totaling $602,000 from investors during the first nine months of fiscal 2018. Additional repurchase requests may have been settled that did not result in the repurchase of the loan itself. The primary reasons for honoring the repurchase requests are borrower fraud, undisclosed liabilities on borrower applications, and documentation, verification and appraisal disputes. For the third quarters of fiscal 2019 and 2018, the Corporation did not record any provision for the recourse liability and did not settle any claims. For the first nine months of fiscal 2019 and 2018, the Corporation recorded a $33,000 recovery and a $22,000 recovery from the recourse liability, respectively, and did not settle any claims. As of March 31, 2019, the total recourse reserve for loans sold that are subject to repurchase decreased to $250,000, as compared to $283,000 at June 30, 2018 and $283,000 at March 31, 2018. Beginning in 2008, in connection with the downturn in the real estate market, the Corporation implemented tighter underwriting standards to reduce potential loan repurchase requests, including requiring higher credit scores, generally lower debt-to-income ratios, and verification of income and assets, among other criteria. Despite management’s diligent estimate of the recourse reserve, the Corporation is still subject to risks and uncertainties associated with potentially higher loan repurchase claims from investors, and there are no assurances that the current recourse reserve will be sufficient to cover all future recourse claims. The following table shows the summary of the recourse liability for the quarters and nine months ended March 31, 2019 and 2018:
|  | For the Quarters Ended March 31, |  |  | For the Nine Months Ended March 31, |
Recourse Liability |  | 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |
(In Thousands) |  |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of the period |  | $ | 250 |  |  | $ | 283 |  |  | $ | 283 |  |  | $ | 305 |
Recovery from recourse liability |  |  | — |  |  |  | — |  |  |  | (33 | ) |  |  | (22 | )
Net settlements in lieu of loan repurchases |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Balance, end of the period |  | $ | 250 |  |  | $ | 283 |  |  | $ | 250 |  |  | $ | 283 |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration